Benfotiamine 120 C by Xymogen
Benfotiamine 120 C is a multi-purpose product designed by Xymogen.* You can take it as a cardiovascular supplement, as well as to promote your nerve health and thiamin status.* It contains Benfotiamine, a lipid-soluble derivative of thiamin that can be absorbed more effectively by your body and can support your conversion of harmful glucose metabolites, hence its potential health benefits.*
Who Should Consider Benfotiamine 120 C?
Benfotiamine 120 C may support your health if you:
- struggle with nerve discomfort, tingling or numbness in your hands and feet*
- want to reduce the impact of high glucose levels*
- wish to support your overall health and wellness*
Benfotiamine 120 C by Xymogen—Effects
Xymogen Benfotiamine 120 C may:
- support healthy thiamin status*
- aid vascular health*
- promote nerve health*
Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Book a FREE product consultation to learn more about Benfotiamine 120 C by Xymogen.
Recommendation:
Xymogen suggests taking two capsules in the morning and two capsules in the evening, or as directed by your healthcare professional.
Serving Size: 2 Capsules
Servings Per Container: 60
Amount Per Serving:
Benfotiamine 300 mg
Other Ingredients: Microcrystalline cellulose, capsule (hypromellose and water), ascorbyl palmitate, silica, and medium-chain triglyceride oil.
Does Not Contain: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, artificial sweeteners, or preservatives.
Caution: Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.
Storage: Keep tightly closed in a cool, dry place.
LEGAL NOTICE: Xymogen's Exclusive Professional Formulas are available through select licensed health care professionals. The Internet Sale and Discounting of XYMOGEN formulas are strictly prohibited. covenanthealthproducts.com makes XYMOGEN formulas available only to patients of our clinic. If you are a patient of covenanthealthproducts.com, you may inquire about XYMOGEN by calling (800) 627-6518
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Click here to view Product Info Sheet
References:
- Winkler, G., Pál, B., Nagybégányi, E., Ory, I., Porochnavec, M., & Kempler, P. (1999). Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy. Arzneimittelforschung, 49(3), 220–224. https://doi.org/10.1055/s-0031-1300405
- Loew, D. (1996). Pharmacokinetics of thiamine derivatives especially of benfotiamine. International Journal of Clinical Pharmacology and Therapeutics, 34(2), 47–50. https://pubmed.ncbi.nlm.nih.gov/8929745/
- Brownlee, M. (2005). The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 54(6), 1615–1625. https://doi.org/10.2337/diabetes.54.6.1615
- Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
- Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P. P., Hannak, D., Neumaier, M., Bergfeld, R., Giardino, I., & Brownlee, M. (2003). Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine, 9(3), 294–299. https://doi.org/10.1038/nm834
- Balakumar, P., Rohilla, A., Krishan, P., & Thangathirupathi, A. (2010). The multifaceted therapeutic potential of benfotiamine. Pharmacological Research, 61(6), 482–488. https://doi.org/10.1016/j.phrs.2010.02.004
- Thornalley, P. J. (2005). The potential role of thiamine (vitamin B1) in diabetic complications. Current Diabetes Reviews, 1(3), 287–298. https://doi.org/10.2174/157339905774574593